SCHEMBL17848348

SCHEMBL17848348

FC(F)(F)c1ccccc1OCCN1CCCCC1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.73
PTGS2 P35354 1/20 0.73
CYP1A2 P05177 1/20 0.71
CYP2D6 P10635 1/20 0.71
CYP2C19 P33261 1/20 0.71
HSD17B10 Q99714 1/20 0.71
DRD2 P14416 5/20 0.62
TSHR P16473 1/20 0.61
ALDH1A1 P00352 1/20 0.59
TDP1 Q9NUW8 1/20 0.59
HTR1A P08908 1/20 0.57
HTR7 P34969 1/20 0.57
HRH1 P35367 3/20 0.56
DRD1 P21728 2/20 0.56
DRD4 P21917 2/20 0.56
DRD5 P21918 2/20 0.56
DRD3 P35462 2/20 0.56
MEN1 O00255 1/20 0.55
GAA P10253 1/20 0.55
MAPT P10636 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14970707 1.00 LTA4H (0.73) LTA4HPTGS2CYP1A2CYP2D6CYP2C19
Hydrochloric Acid SCHEMBL14969001 0.98 LTA4H (0.71) LTA4HPTGS2CYP1A2CYP2D6CYP2C19
SCHEMBL7601343 0.85 HTR2C (0.60) LTA4HPTGS2CYP1A2CYP2D6CYP2C19
SCHEMBL16643959 0.85 CYP2D6 (0.97) LTA4HPTGS2CYP1A2CYP2D6CYP2C19
SCHEMBL17848431 0.84 DRD2 (0.61) LTA4HPTGS2CYP1A2CYP2D6CYP2C19
SCHEMBL17848474 0.84 DRD2 (0.58) LTA4HPTGS2CYP1A2CYP2D6CYP2C19
SCHEMBL12218602 0.83 CYP2D6 (1.00) LTA4HPTGS2CYP1A2CYP2D6CYP2C19
SCHEMBL17848636 0.83 HTR7 (0.61) LTA4HPTGS2CYP1A2CYP2D6CYP2C19
SCHEMBL17848618 0.83 HTR1A (0.61) LTA4HPTGS2CYP1A2CYP2D6CYP2C19
SCHEMBL17848384 0.81 DRD2 (0.71) LTA4HPTGS2CYP1A2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3233077-A1 DOPAMINE D2 RECEPTOR LIGANDS The Broad Institute Inc. (US) 2017-10-25 EP disclosed
WO-2016100940-A1 DOPAMINE D2 RECEPTOR LIGANDS THE BROAD INSTITUTE, INC. (US) 2016-06-23 WO disclosed